Home > Cashflow Statement > INDO US BIOTECH

INDO US BIOTECH
Cash Flow from Operating Activities

    Back to Cashflow Statement
INDO US BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Last 5 Year Cash Flow from Operating Activities History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹1.42 Cr₹-4.58 Cr₹0.53 Cr₹2.91 Cr₹0.22 Cr

What is the latest Cash Flow from Operating Activities ratio of INDO US BIOTECH ?

The latest Cash Flow from Operating Activities ratio of INDO US BIOTECH is ₹1.42 Cr based on Mar2025 Standalone results.
Year Cash Flow from Operating Activities
Mar2025₹1.42 Cr
Mar2024₹-4.58 Cr
Mar2023₹0.53 Cr
Mar2022₹2.91 Cr
Mar2021₹0.22 Cr

How is Cash Flow from Operating Activities of INDO US BIOTECH Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹1.42 Cr
Positive
Mar2024 ₹-4.58 Cr
Negative
Mar2023 ₹0.53 Cr
-81.91
Mar2022 ₹2.91 Cr
1,192.44
Mar2021 ₹0.22 Cr -

Compare Cash Flow from Operating Activities of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹199.3 Cr -12.3% -26.6% -49% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,634.6 Cr -3.3% -13.1% -10.9% Stock Analytics
KAVERI SEED COMPANY ₹4,168.6 Cr 6.8% -10.7% -24.8% Stock Analytics
VENKYS (INDIA) ₹1,709.7 Cr -2.3% -14.4% -21.8% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹861.0 Cr -0.5% -9.2% -39.7% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹336.5 Cr 2.8% -19.9% -35.8% Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

-12.3%

-26.6%

-49%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses